ArticleScientific reports2020

Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis.

Emanuele Sasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.